Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.
DSpace/Manakin Repository
Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.
Peipp, M.; Schneider-Merck, T.; Dechant, M.; Beyer, T.; Lammerts van Bueren, J.J.; Bleeker, W.K.; Parren, P.W.H.I.; van de Winkel, J.G.J.; Valerius, T.
(2008) Journal of Immunology, volume 180, issue 6, pp. 4338 - 4345